Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

16,16-dimethyl prostaglandin E2-loaded poly(lactic-coglycolic acid)-b-poly(ethylene glycol)-conjugated endothelial-targeted peptide nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

PLGA-b-PEG/PLGA-b-PEG-iRGO

Type Complex Compound
Formula
Role carriers
2

16,16-dimethyl prostaglandin E2

Type Single Compound
Formula C22H36O5
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
C57BL/6 mouse

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(lactic-coglycolic acid)-b-poly(ethylene glycol)
  • poly(lactic-coglycolic acid)-b-poly(ethylene glycol)-maleimide-conjugated iRGD peptide
  • 16,16-dimethyl prostaglandin E2
  1. qxxlRbc1qcVnYIiqMf9g681B
  2. 05xCr
  3. iQP
  4. Mm6RwUk3K7
Product

16,16-dimethyl prostaglandin E2-loaded poly(lactic-coglycolic acid)-b-poly(ethylene glycol)-conjugated endothelial-targeted peptide nanoparticles

Size: not specified

Medium: water

Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • poly(lactic-coglycolic acid)-b-poly(ethylene glycol)
  • poly(lactic-coglycolic acid)-b-poly(ethylene glycol)-maleimide-conjugated P3 peptide
  • 16,16-dimethyl prostaglandin E2
  1. oNermbEvBDI6HMVvZpU9Wezo
  2. 9Y6IW
  3. W7P
  4. Fpaut2v879
Product

16,16-dimethyl prostaglandin E2-loaded poly(lactic-coglycolic acid)-b-poly(ethylene glycol)-conjugated endothelial-targeted peptide nanoparticles

Size: not specified

Medium: water

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial